Compounds > parecoxib
Page last updated: 2024-09-03

parecoxib and Colorectal Neoplasms

parecoxib has been researched along with Colorectal Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, Z; Zheng, J; Zhu, J1
Ai, YQ; Bai, H; Chang, L; Jiang, YX; Li, WH; Liu, R; Liu, S; Tan, J; Wang, H; Wang, XL; Xiong, W; Zhang, M; Zheng, R1
Cacheux, W; Chaussade, S; de Reyniès, A; Hamzaoui, N; Lamarque, D; Perret, C; Romagnolo, B; Terris, B; Zagani, R1
Bloemendaal, AL; Borel Rinkes, IH; Kranenburg, O; Smakman, N; van Diest, P; Vogten, JM1

Trials

1 trial(s) available for parecoxib and Colorectal Neoplasms

ArticleYear
Effect of preintravenous injection of parecoxib, combined with transversus abdominis plane block in strategy of enhanced recovery after radical resection of colorectal cancer.
    Journal of cancer research and therapeutics, 2018, Volume: 14, Issue:7

    Topics: Adolescent; Adult; Aged; Colorectal Neoplasms; Combined Modality Therapy; Cyclooxygenase 2 Inhibitors; Female; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pain Measurement; Pain, Postoperative; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2018

Other Studies

3 other study(ies) available for parecoxib and Colorectal Neoplasms

ArticleYear
Parecoxib: an enhancer of radiation therapy for colorectal cancer.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:2

    Topics: Animals; Apoptosis; Blotting, Western; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Flow Cytometry; Humans; Hypoxia; Immunoenzyme Techniques; Isoxazoles; Male; Mice; Mice, Nude; Radiation-Sensitizing Agents; Tumor Cells, Cultured; X-Rays; Xenograft Model Antitumor Assays

2015
Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Gastroenterology, 2009, Volume: 137, Issue:4

    Topics: Adenomatous Polyposis Coli; Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Cell Survival; Colonic Polyps; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase Inhibitors; DNA-Binding Proteins; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, APC; Humans; Isoxazoles; Lactones; Mice; Mice, Mutant Strains; Nuclear Receptor Subfamily 4, Group A, Member 2; Oligonucleotide Array Sequence Analysis; Osteopontin; Promoter Regions, Genetic; RNA Interference; Signal Transduction; Sulfones; Time Factors; Transcription Factors; Transfection; Wnt Proteins

2009
Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jan-01, Volume: 11, Issue:1

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Genes, ras; Image Processing, Computer-Assisted; Immunohistochemistry; Isoxazoles; Ki-67 Antigen; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Microcirculation; Mutation; Neoplasm Metastasis; Neoplasm Transplantation; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Proteins p21(ras); RNA Interference; Time Factors

2005